Tenon Medical Q2 2024 GAAP EPS $(1.02) Beats $(1.08) Estimate, Sales $901.00K Miss $909.50K Estimate
Portfolio Pulse from Benzinga Newsdesk
Tenon Medical (NASDAQ:TNON) reported Q2 2024 GAAP EPS of $(1.02), beating the estimate of $(1.08). However, sales of $901K missed the $909.5K estimate. Sales increased by 21.27% year-over-year.
August 13, 2024 | 8:14 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Tenon Medical reported a better-than-expected EPS of $(1.02) for Q2 2024, beating the $(1.08) estimate. However, sales of $901K missed the $909.5K estimate. Sales increased by 21.27% year-over-year.
The better-than-expected EPS is a positive indicator and may boost investor confidence, leading to a potential short-term price increase. However, the slight miss in sales could temper the enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100